Category: Generics Drugs
Australia Generics Drugs
-
Asia Pacific Multiple Sclerosis Drugs Market, By Disease Type (Relapsing-Remitting Multiple Sclerosis (RRMS), Secondary Progressive Multiple Sclerosis (SPMS), Primary Progressive Multiple Sclerosis (PPMS), Severe Relapsing-Remitting Multiple Sclerosis (RES)); By Treatment (Preventive Therapies, Abortive Therapies/Treatment of Acute Exacerbations, Symptomatic Therapies); By Drug Type (Branded, Generic); By End User (Hospital & Clinics, Diagnostic Laboratories); By Country (China, India, Japan, South Korea, Australia & New Zealand, Indonesia, Malaysia, Singapore, Vietnam, Rest of APAC), Competitive Landscape & Forecast, 2019–2029
... End User (Pharmaceutical & Biopharmaceutical Companies, Labs & Research Institutes, Healthcare Providers, Healthcare Payers); By Application (Drug Discovery & Development, Medical Diagnostics, Genomics & Precision Medicine, Radiotherapy, Risk Analysis); By Region (North America, Europe, Asia ... Read More
-
Australia Generics Market Summary, Competitive Analysis and Forecast to 2027
... contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Key Highlights For the purposes of this profile, a generic drug is defined as a copy of ... Read More
-
Australia Generics Market Summary, Competitive Analysis and Forecast, 2017-2026
... descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Key Highlights For the purposes of this profile, a generic drug is defined as a copy of an ... Read More
Research Assistance
